Analysis

Morgan Stanley Reiterates Equalweight Rating for Solventum, Highlights Focus on Culture and Growth Repositioning

09/06/2024

News

Solventum to Participate in the Piper Sandler Healthcare Conference

ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 at 11:30 a.m.

11/19/2024

SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments

Solventum's Clarity precision grip attachments enhance treatment outcomes for orthodontic patients, reducing the risk of misplaced and malformed attachments.

11/15/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is (SOLV) a buy, sell, or hold?

(SOLV) can sell. Click on Rating Page for detail.

What is 's stock price?

The price of (SOLV) is 67.12 and it was updated on 2025-01-04 07:58:27.

Is (SOLV) overvalued or undervalued?

Currently (SOLV) is in undervalued.

News

From:

To:

News
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment Clarity Precision Grip Attachments are fully cured, pre-loaded and precisely resemble the digital treatment plan after bonding ST. PAUL, Minn. Thu, Nov. 14, 2024
Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript Solventum Corporation (NYSE:SOLV ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kevin Moran - SVP, IR Bryan Hanson - CEO Wayde McMillan - CFO Conference Call Participants Travis Steed - Bank of America Patrick Wood - Morgan Stanley Vik Chopra - Wells Fargo David Roman - Goldman Sachs Rick Wise - Stifel Ryan Zimmerman - BTIG Jason Bednar - Piper Sandler Chris Senyek - Wolfe Research Operator Good afternoon. My name is Amy, and I will be your conference operator for today. Fri, Nov. 08, 2024
SOLV Stock Gains as Q3 Earnings & Sales Beat Estimates, '24 View Up Solventum's top line reflects the favorable impact of pricing normalization. Organic growth is primarily driven by rising demand for MedSurg products. Fri, Nov. 08, 2024
Solventum raises annual profit forecast on strong surgical product sales 3M spin-off Solventum raised its annual profit forecast on Thursday, betting on strong sales of its wound care and surgical sterilization products. Thu, Nov. 07, 2024
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70; adjusted EPS1 of $1.64 Generated $169 million in cash from operations; free cash flow1 of $76 million Raises full-year 2024 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, Minn. Thu, Nov. 07, 2024

Transcripts

Transcipts Data
(SOLV) on Q2 2024 Results - Earnings Call Transcript SA Transcripts Sat, Aug. 10, 2024

SEC Filings

SEC Filings
(SOLV) - EFFECT SEC Filings 12/18/2024
(SOLV) - POS AM SEC Filings 12/11/2024
(SOLV) - 4/A SEC Filings 12/10/2024
(SOLV) - EFFECT SEC Filings 12/03/2024
(SOLV) - 4 SEC Filings 12/03/2024
(SOLV) - 424B3 SEC Filings 12/02/2024
(SOLV) - S-4 SEC Filings 11/15/2024
(SOLV) - SCHEDULE 13G SEC Filings 11/14/2024
(SOLV) - SC 13G/A SEC Filings 11/12/2024
(SOLV) - SC 13G SEC Filings 11/08/2024
(SOLV) - IRANNOTICE SEC Filings 11/08/2024
(SOLV) - 10-Q - Quarterly Report SEC Filings 11/08/2024
(SOLV) - 8-K - Current report SEC Filings 11/07/2024
(SOLV) - 8-K - Current report SEC Filings 11/05/2024
(SOLV) - SC 13G/A SEC Filings 11/04/2024
(SOLV) - SC 13G SEC Filings 10/24/2024
(SOLV) - 8-K - Current report SEC Filings 09/26/2024
(SOLV) - 4 SEC Filings 09/04/2024
(SOLV) - 4 SEC Filings 08/14/2024
(SOLV) - IRANNOTICE SEC Filings 08/09/2024
(SOLV) - 10-Q - Quarterly Report SEC Filings 08/09/2024
(SOLV) - 8-K - Current report SEC Filings 08/08/2024
(SOLV) - 8-K - Current report SEC Filings 05/17/2024
(SOLV) - 4 SEC Filings 05/15/2024
(SOLV) - 10-Q - Quarterly Report SEC Filings 05/10/2024
(SOLV) - 8-K - Current report SEC Filings 05/09/2024
(SOLV) - 8-K - Current report SEC Filings 04/16/2024
(SOLV) - 3 SEC Filings 04/16/2024
(SOLV) - 8-K - Current report SEC Filings 04/04/2024
(SOLV) - 4 SEC Filings 04/03/2024
(SOLV) - 3 SEC Filings 04/02/2024
(SOLV) - S-8 SEC Filings 04/01/2024
(SOLV) - 4 SEC Filings 03/26/2024
(SOLV) - SEC STAFF LETTER SEC Filings 03/13/2024
(SOLV) - SEC STAFF ACTION SEC Filings 03/13/2024
(SOLV) - 8-K - Current report SEC Filings 03/13/2024
(SOLV) - 3 SEC Filings 03/13/2024
(SOLV) - CORRESP SEC Filings 03/12/2024
(SOLV) - CERT SEC Filings 03/12/2024
(SOLV) - 10-12B/A SEC Filings 03/11/2024
(SOLV) - 10-12B/A SEC Filings 03/06/2024
(SOLV) - CORRESP SEC Filings 03/05/2024
(SOLV) - UPLOAD SEC Filings 03/01/2024
(SOLV) - SEC STAFF LETTER SEC Filings 02/27/2024
(SOLV) - CORRESP SEC Filings 02/20/2024
(SOLV) - 10-12B SEC Filings 02/20/2024
(SOLV) - UPLOAD SEC Filings 02/15/2024
(SOLV) - DRSLTR SEC Filings 02/09/2024
(SOLV) - DRS/A SEC Filings 02/09/2024
(SOLV) - UPLOAD SEC Filings 02/05/2024
(SOLV) - DRSLTR SEC Filings 01/26/2024
(SOLV) - DRS/A SEC Filings 01/26/2024
(SOLV) - UPLOAD SEC Filings 01/05/2024
(SOLV) - DRS/A SEC Filings 12/18/2023
(SOLV) - DRSLTR SEC Filings 09/13/2023
(SOLV) - DRS/A SEC Filings 09/13/2023
(SOLV) - UPLOAD SEC Filings 08/11/2023
(SOLV) - DRSLTR SEC Filings 07/28/2023
(SOLV) - DRS/A SEC Filings 07/28/2023
(SOLV) - UPLOAD SEC Filings 07/10/2023
(SOLV) - DRSLTR SEC Filings 06/23/2023
(SOLV) - DRS/A SEC Filings 06/23/2023
(SOLV) - UPLOAD SEC Filings 06/06/2023
(SOLV) - DRS/A SEC Filings 05/16/2023
(SOLV) - DRSLTR SEC Filings 05/15/2023
(SOLV) - UPLOAD SEC Filings 03/15/2023
(SOLV) - DRS SEC Filings 02/14/2023

Press Releases

StockPrice Release
Solventum to participate in the piper sandler healthcare conference 11/19/2024
Solventum launches first 3d printed aligner attachments to revolutionize aligner treatment 11/14/2024
Solventum reports third quarter 2024 financial results and raises full-year guidance 11/07/2024
Solventum to report third quarter 2024 financial results and host conference call on november 7, 2024 10/15/2024
Solventum announces commitment to 100% renewable electricity by 2030 10/14/2024
Solventum names surgeon and diagnostics pioneer dr. ryan egeland as chief medical officer 10/10/2024
Solventum launches all-in-one, extended-wear wound dressing for v.a.c.® therapy 09/10/2024
Solventum to participate in upcoming investor conferences 08/28/2024
Solventum autonomous coding listed in epic toolbox 08/20/2024
Solventum reports second quarter 2024 financial results and raises full-year guidance 08/08/2024
Solventum to report second quarter 2024 financial results and host conference call on august 8, 2024 07/16/2024
U.s. news & world report expands use of solventum's ambulatory potentially preventable complications grouping software for use in its 2024-2025 best hospitals rankings 07/02/2024
Solventum introduces denials prevention solution, an ai-powered tool, empowering health systems to help reduce write-offs and improve top line revenue 06/24/2024
Solventum cautions investors regarding trc capital's "mini-tender offer" 06/07/2024
Trc amends its tender offer for solventum corporation 06/06/2024
Solventum reports first quarter 2024 financial results and capital allocation update 05/09/2024
Solventum announces first quarter 2024 earnings release date and upcoming investor events 04/23/2024
Solventum names shirley edwards to board of directors 04/15/2024
Solventum begins trading on the new york stock exchange 04/01/2024
Ge vernova and solventum set to join s&p 500; dentsply sirona to join s&p midcap 400; others to join s&p smallcap 600 03/27/2024

More Headlines

News
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend SOLV's Q3 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency headwinds. Improved pricing might have offset sales decline. 11/06/2024
Why Investors Need to Take Advantage of These 2 Medical Stocks Now Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. 11/04/2024
Solventum Taps Bankers to Explore Sale of Filtration Unit The business is expected to draw takeover interest from private equity and strategic buyers. 10/24/2024
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report? Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 10/15/2024
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024 ST. PAUL, Minn. , Oct. 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close. 10/15/2024
Solventum Announces Commitment to 100% Renewable Electricity by 2030 ST. PAUL, Minn. , Oct. 14, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030. 10/14/2024
Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer ST. PAUL, Minn. , Oct. 10, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that Dr. Ryan Egeland, MD, has been named chief medical officer. 10/10/2024
Buy 4 October Dividend Aristocrats & Watch 10 "Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 10.5%-20.13% topped-by Franklin & Target. 10/09/2024
SOLV or MEDP: Which Is the Better Value Stock Right Now? Investors with an interest in Medical Services stocks have likely encountered both Solventum (SOLV) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now? 10/03/2024
Invest Alongside Wall Street Legend Seth Klarman: 2 New Stocks He Bought and 1 He Dumped Enigmatic investing legend Seth Klarman runs the Boston-based Baupost Group hedge fund that has around $27 billion in assets under management. 09/29/2024
26 Millionaires and Billionaires Can't Be Wrong. The One Stock All of Them Are Buying Watching what the smart money is buying can be a useful investment strategy. 09/28/2024
Billionaire Nelson Peltz Unveiled 3 New Stocks in His Very Focused Portfolio Nelson Peltz isn't one to shy away from a fight. 09/28/2024
SOLV vs. DOCS: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Doximity (DOCS). But which of these two companies is the best option for those looking for undervalued stocks? 09/16/2024
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy SOLV announces the launch of its V.A.C. Peel and Place Dressing for providing efficient and effective care in case of negative pressure wound therapy. 09/11/2024
Buy 4 September Dividend Aristocrats And Watch 6 The S&P 500 Dividend Aristocrats list was rebalanced in January 2024, with notable changes including the removal of Walgreens and 3M, and the addition of Fastenal and Kenvue. 09/10/2024
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy New V.A.C.® Peel and Place Dressing makes negative pressure wound therapy more accessible, less painful ST. PAUL, Minn. 09/10/2024
Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months. 09/09/2024
2 Spinoff Stocks Down 16%. Should You Buy Now? Stock spinoffs are a popular corporate strategy for unlocking shareholder value, but one that rarely pays off for investors. 08/30/2024
Solventum to Participate in Upcoming Investor Conferences ST. PAUL, Minn. , Aug. 28, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m. 08/28/2024
Trade Tracker: Jenny Harrington sells Solventum Corp. Jenny Harrington, CEO Gilman Hill Asset Management, joins CNBC's "Halftime Report" to explain why she's getting out of Solventum. 08/23/2024
Solventum autonomous coding listed in Epic Toolbox ST. PAUL, Minn., Aug. 20, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced that its autonomous coding solution has received Toolbox designation from Epic in the Fully Autonomous Coding category. 08/20/2024
Solventum's (SOLV) Q2 Earnings Beat Estimates, ' 24 View Raised Solventum's (SOLV) second-quarter results show resilience in MedSurg and Health Information Systems. Its shrinking margins pose concerns. 08/14/2024
Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript Solventum Corporation (NYSE:SOLV ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Kevin Moran - Senior Vice President, Investor Relations Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Vik Chopra - Wells Fargo David Roman - Goldman Sachs Operator Good day. My name is Ellie, and I will be your conference operator for today. 08/10/2024
Solventum's second-quarter profit falls 70% on higher expenses 3M spin-off Solventum's second-quarter profit fell more than 70% on Thursday, hurt by limited sales growth of its wound care and surgical sterilization products and higher expenses, as it navigates functioning as a newly independent company. 08/08/2024
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56 Generated $355 million in cash from operations; free cash flow1 of $297 million Raises full-year 2024 organic sales growth and adjusted EPS guidance ST. PAUL, Minn. 08/08/2024
4 Dividend Aristocrats To Buy In August And More To Watch “Dividend Aristocrats… in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years.“- Kiplinger.. 67 Aristocrats, screened as of August 2, 2024, represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 8.12%-27.1% topped by CVX & TGT. 08/06/2024
Curreen Capital: Ugly Ducklings Selling At An Attractive Price We were more active than usual in the quarter, buying shares that were available at very attractive prices. All in, we have ugly ducklings - high returns on capital, cash cow spinoffs, working through resolvable issues, and selling at attractive prices. I love buying businesses like this, and if it drops to my next buy price, we will add to it. 07/27/2024
Activist Trian has a few levers to pull to build shareholder value at Solventum Since its spinoff from 3M, Solventum has been under-covered and misunderstood by the market. 07/27/2024
SOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake Solventum (NYSE: SOLV ) stock is up on Tuesday after activist investor Trian Capital took a stake in the healthcare company. According to insider sources, Trian Capital has taken a large stake in the company. 07/23/2024
Solventum Stock Jumps as Activist Trian Discloses Stake The move comes just months after 3M spun off the healthcare product company. 07/22/2024
Nelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports Activist investor Nelson Peltz's Trian Fund Management has built a stake in 3M's healthcare spinoff Solventum , Bloomberg News reported on Monday, citing people with knowledge of the matter, sending shares of the company up 3.4% after the bell. 07/22/2024
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 ST. PAUL, Minn., July 16, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close. 07/16/2024
U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings ST. PAUL, Minn., July 2, 2024 /PRNewswire/ -- Solventum today announced that U.S. News & World Report is expanding its use of Solventum's 3M™ Ambulatory Potentially Preventable Complications (AM-PPCs) software in the analysis of its 2024-2025 Best Hospitals rankings. 07/02/2024
Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue ST. PAUL, Minn., June 24, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solution, Solventum™ Revenue Integrity System. 06/24/2024
Contrarian Plays: 3 Stocks to Buy When Analysts Say ‘Sell' Wall Street loves winners. They enjoy backing stocks that are rising and want to avoid stocks that are falling. 06/18/2024
3M Company: Solventum Spinoff Creates More Upside Potential Despite the strong rally recently, I see more upside for 3M Company stock prices. The top drivers include the Solventum Corporation spin-off and the settlement of its legacy lawsuits, both enhancing the clarity of its growth curve ahead. The attractive valuation multiples add further upside potential. 06/17/2024
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer" ST. PAUL, Minn., June 7, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at $59.15 per share and decreased the offer price on June 6, 2024, to $55.00 per share. 06/07/2024
TRC Amends Its Tender Offer for Solventum Corporation TORONTO, June 06, 2024 (GLOBE NEWSWIRE) -- TRC Capital Investment Corporation (TRC) announced today that based on current market conditions, TRC has amended the terms of its tender offer for up to 2,000,000 common shares of Solventum Corporation (the Company) and has decreased the offer price payable to US$55.00 per share from US$59.15 per share. 06/06/2024
Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market Too often spinoff stocks don't perform well out of the gate. Because an investor bought the business of the parent company, he doesn't care too much about whatever side project is being shed. 05/16/2024
The 'Undercovered' Dozen From April 2024 The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. QuantumScape, IonQ, Enbridge preferred shares, Tilray, and more are included this month. 05/10/2024
Solventum Reports Earnings. There Will Be No Dividend. 3M healthcare spinoff Solventum says it will prioritize paying back debt over dividends and share buybacks for the next 24 months. 05/09/2024
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update Completed spin-off from 3M and began trading on April 1, 2024 Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS1 of $2.08 Generated $442 million in cash from operations; free cash flow1 of $340 million Reaffirms full-year 2024 guidance ST. PAUL, Minn. 05/09/2024
Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle? There's a lot of evidence suggesting that spinoff stocks are generally a good idea to watch. Following a split from their parent company, many such firms do well thanks to their efficiency and newly-found flexibility. 05/06/2024
Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events ST. PAUL, Minn. , April 23, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it will release carve-out financial results for the first quarter 2024 before the market opens on May 9, 2024. 04/23/2024
Solventum Names Shirley Edwards to Board of Directors ST. PAUL, Minn. , April 15, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its Board of Directors appointed Shirley Edwards, former partner, EY, to the board. 04/15/2024
Solventum Stock Is Cheap. Why Wall Street Says to Wait. The 3M healthcare spinoff picked up two new ratings this week. 04/12/2024
3M Spun Off Its Health Division, Is It Still A Buy? Investors woke up this week to find shares of 3M NYSE: MMM trade lower by roughly 20%. What seemed to be a recovery is now a scary environment for 3M shareholders. 04/04/2024
I like Solventum's core business, but it isn't the cleanest of stories, says Jim Cramer 'Mad Money' host Jim Cramer takes a closer look at 3M spin-off company Solventum. 04/01/2024
3M Finalizes Drinking Water Settlement Amidst Solventum Spinoff Solventum (NYSE: SOLV ) stock went live on the New York Stock Exchange today just as its parent company, 3M (NYSE: MMM ), sorted out a recent settlement related to a drinking water agreement. Indeed, on March 29, 3M announced that its prior settlement agreement with U.S. public water suppliers had received final approval in U.S. District Court. 04/01/2024
Should You Buy Solventum (SOLV) Stock After the 3M Spinoff? Healthcare business Solventum (NYSE: SOLV ) — which covers information technology, wound care and other specialties — slipped on its public market debut. SOLV stock represents a spinoff from industrial conglomerate and applied sciences giant 3M (NYSE: MMM ). 04/01/2024
3M Completes Health Care Spinoff, and a Court Finalizes 'Forever Chemicals' Settlement Two big announcements from 3M (MMM) sent shares of the conglomerate higher Monday. 04/01/2024
3M Spinoff Solventum Stock Is Down 16%. What Happens Next. The spinoff of 3M's healthcare business is complete and shares of the new company, called Solventum, are lower. It could be a buying opportunity. 04/01/2024
3M healthcare spinoff Solventum slides on NYSE debut Solventum Corp (NYSE: SOLV) lost about 3.0% as it debuted on the New York Stock Exchange on Monday. The healthcare name was separated from 3M & Co (NYSE: MMM) in March. 04/01/2024
SOLV Stock: 7 Things to Know as Solventum Starts Trading Today Solventum (NYSE: SOLV ), the healthcare company spun off by 3M (NYSE: MMM ), has started trading independently today on the New York Stock Exchange. Here are seven things investors should know about the spinoff, 3M and it shares, and Solventum and SOLV stock. 04/01/2024
Solventum Begins Trading on the New York Stock Exchange Formerly 3M Health Care Business, Solventum (NYSE: SOLV) enables better, smarter, safer healthcare to improve lives ST. PAUL, Minn. 04/01/2024
GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600 NEW YORK , March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE: SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE: VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. 03/27/2024
GE Vernova, Solventum to join S&P 500 index next week Newly minted GE Vernova and Solventum Corp., both soon to be officially spun off from two industrial giants, are hitting it big early: They are joining the S&P 500 index next week. 03/27/2024
These GE and 3M Spinoffs Are Set to Join the S&P 500 S&P Dow Jones Indices announced changes to its indexes as of the start of the second quarter. 03/27/2024

Unlock

SOLV Ratings Summary

SOLV Quant Ranking

Is (SOLV) a buy, sell, or hold?

What is 's stock price?

Is (SOLV) overvalued or undervalued?

Solventum Q3 Earnings Likely to Reflect Declining Volume Trend

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Solventum Taps Bankers to Explore Sale of Filtration Unit

Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?

Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Solventum Announces Commitment to 100% Renewable Electricity by 2030

Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer

Buy 4 October Dividend Aristocrats & Watch 10

SOLV or MEDP: Which Is the Better Value Stock Right Now?

Invest Alongside Wall Street Legend Seth Klarman: 2 New Stocks He Bought and 1 He Dumped

26 Millionaires and Billionaires Can't Be Wrong. The One Stock All of Them Are Buying

Billionaire Nelson Peltz Unveiled 3 New Stocks in His Very Focused Portfolio

SOLV vs. DOCS: Which Stock Is the Better Value Option?

Solventum Shares May Gain on the Launch of Its New V.A.C Therapy

Buy 4 September Dividend Aristocrats And Watch 6

Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy

Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus

2 Spinoff Stocks Down 16%. Should You Buy Now?

Solventum to Participate in Upcoming Investor Conferences

Trade Tracker: Jenny Harrington sells Solventum Corp.

Solventum autonomous coding listed in Epic Toolbox

Solventum's (SOLV) Q2 Earnings Beat Estimates, ' 24 View Raised

Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript

Solventum's second-quarter profit falls 70% on higher expenses

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

4 Dividend Aristocrats To Buy In August And More To Watch

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

Activist Trian has a few levers to pull to build shareholder value at Solventum

SOLV Stock Alert: Solventum Pops as Activist Investor Trian Capital Takes Stake

Solventum Stock Jumps as Activist Trian Discloses Stake

Nelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports

Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings

Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue

Contrarian Plays: 3 Stocks to Buy When Analysts Say ‘Sell'

3M Company: Solventum Spinoff Creates More Upside Potential

Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

TRC Amends Its Tender Offer for Solventum Corporation

Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market

The 'Undercovered' Dozen From April 2024

Solventum Reports Earnings. There Will Be No Dividend.

Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update

Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?

Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events

Solventum Names Shirley Edwards to Board of Directors

Solventum Stock Is Cheap. Why Wall Street Says to Wait.

3M Spun Off Its Health Division, Is It Still A Buy?

I like Solventum's core business, but it isn't the cleanest of stories, says Jim Cramer

3M Finalizes Drinking Water Settlement Amidst Solventum Spinoff

Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?

3M Completes Health Care Spinoff, and a Court Finalizes 'Forever Chemicals' Settlement